Latest news & insights
Further growth for regulatory affairs team at Boyds with appointment of Harriet Edwards
We are pleased to announce the appointment of experienced regulatory professional, Harriet Edwards, in response to a sustained rise in demand for specialist regulatory services
Rare Disease Day: Gene therapy trends and innovation for rare diseases
To mark Rare Disease Day 2023, Professor Alan Boyd, President and CEO of Boyds, spoke to Cell and Gene Therapy Insights to share his views on gene therapy trends and innovation in the rare and ultra-rare disease spaces.
Eamonn McGowran explains developments in regulation for medical devices in Med-Tech Innovation article
An article published in Med-Tech Innovation and authored by Eamonn McGowran, explains the developments in regulation for Medical devices.
Dr Karen Mullen interviewed for pharmaphorum article
Dr Karen Mullen, Chief Medical Officer at Boyds, recently sat down with pharmaphorum, a leading online destination for healthcare and pharmaceutical industry news.
Boyds regulatory affairs article published by Drug Discovery World
An article authored by Dr Julie Warner, Vice President of Regulatory Affairs, has been featured by Drug Discovery World – the multi-platform global voice for the drug discovery community.
Boyds article published by Clinical Leader
An article authored by Dr Harriet Gray Stephens, Pharmaceutical Physician in Boyds’ Clinical and Medical Affairs team has been featured by Clinical Leader – a
Boyds bolsters regulatory affairs team with key appointment
We are delighted to announce the appointment of experienced regulatory affairs professional and cell and gene therapy expert Dr Patrick Ginty. With 17 years’ R&D
Boyds expands regulatory affairs team with experienced senior hire of Katherine Bowen
We are delighted to announce the appointment of experienced regulatory affairs professional Katherine Bowen in response to a rise in demand for our specialist regulatory
